Patellar Tendinopathy: Difference between revisions

No edit summary
No edit summary
Line 37: Line 37:
== Clinical Presentation  ==
== Clinical Presentation  ==


Patellar tendinopathy, is one of many potential diagnoses for a patient presenting with anterior knee pain. There is considered to be two defining clinical features<ref name='malli' />:<br>


#Pain localized to the inferior pole of the patella
#Load-related pain that increases with the demand on the knee extensors, notably in activities that store and release energy in the patellar tendon.<br>
The patient may complain of pain with prolonged sitting, squatting, and stairs, but these complaints are features of other pathologies such as [[Patellofemoral_Pain_Syndrome|patellofemoral pain]]. Pain is rarely experienced in a resting state. Pain occurs instantly with loading and usually ceases almost immediately when the load is removed. The pain may improve with repeated loading.<br>
<br>


== Diagnostic Procedures  ==
== Diagnostic Procedures  ==

Revision as of 14:57, 16 February 2016

Description[edit | edit source]

Patellar tendinopathy is a source of anterior knee pain, characterised by pain localised to the inferior pole of the patella. Pain is aggravated by loading and increased with the demand on the knee extensor musculature, notably in activities that store and release energy in the patellar tendon[1].

Clinically Relevant Anatomy[edit | edit source]

TendonCS.JPG

Cross section of a tendon. Collagen fibers
make up the pale pink background. The
fine lines separate fibre bundles. Black
dots are the tenocyte nuclei. [2]

The quadriceps muscles are connected to the inferior pole of the patella by the common quadriceps tendon through a sesmoid bone, the patella. The patellar ligament then connects the bottom of the patella to the tibial tuberosity. The force generated from the quadriceps muscles acts through the patellar as a pulley, causing the knee to extend[3]

A healthy tendon is composed mostly of parallel collagen fibers closely packed together (86%)[4]. Collagen is predominantly type I. Other components of the tendon matrix are elastin (2%), proteoglycans (1–5%), and inorganic components (0.2%). The collagen in tendons are held together with proteoglycan components Decorin and Aggrecan, which bind to the collagen fibrils at specific locations[5]

Tenocytes are a tendon specific fibroblast type cells that produce the collagen molecules, which cluster together to fom collagen fibrils. Fibril bundles are organized to form fibres with the elongated tenocytes closely packed between them. The cells communicate with each other through gap junctions, and this signalling gives them the ability to detect and respond to mechanical load[6].

Blood vessels run parallel to collagen fibres within the tendon with some branching transverse anastomoses. There is thought to be no nerve supply to the internal tendon but adjacent to the tendon are nerve endings and Golgi tendon organs are present at the junction between tendon and muscle.

Pathological Process
[edit | edit source]

Clinical Presentation[edit | edit source]

Patellar tendinopathy, is one of many potential diagnoses for a patient presenting with anterior knee pain. There is considered to be two defining clinical features[1]:

  1. Pain localized to the inferior pole of the patella
  2. Load-related pain that increases with the demand on the knee extensors, notably in activities that store and release energy in the patellar tendon.

The patient may complain of pain with prolonged sitting, squatting, and stairs, but these complaints are features of other pathologies such as patellofemoral pain. Pain is rarely experienced in a resting state. Pain occurs instantly with loading and usually ceases almost immediately when the load is removed. The pain may improve with repeated loading.


Diagnostic Procedures[edit | edit source]

Outcome Measures[edit | edit source]

  • Pain provocation
  • Tendon swelling
  • Return to activity

Medical Management
[edit | edit source]

Non-steroidal anti-inflammatory drugs
[edit | edit source]

The use of non-steroidal anti-inflammatory drugs (NSAID’s) in the treatment of tendinopathy remains controversial both in the acute stage and in the chronic stage. NSAIDs have been reported to impede soft tissue healing. Although pain may be reduced, they have a negative effect on tendon repair[7]. In reactive tendinopathy, this may be a preferred effect, as this may inhibit proteins responsible for tendon swelling[8].

Corticosteroid injections
[edit | edit source]

Corticosteroids are used to decrease pain but also decrease cell proliferation and protein production and therefore could be used in the reactive tendinopathies. Repeated peritendinous corticosteroid has been shown to reduce tendon diameter at 7 and 21 days after injection in tendons[9].

Surgical treatment
[edit | edit source]

Surgery for chronic painful tendons has produced varied outcomes, with 50–80% of athletes able to return to sport at their previous level[10]. Surgery in nonathletic people produced poorer results than in active people[11]. Surgery is considered a reasonable option in those who have failed all conservative interventions.

Physiotherapy Management
[edit | edit source]

Advice regarding selective rest should be provided to allow appropriate tendon healing following a period of acute overloading or unaccustomed exercise[12]. There should be a focus on an early return to activities.

Pain relief[edit | edit source]

Isometrics have been suggested as a possible analgesic exercise where isotonic exercises are not possible due to fatigue and high SIN. In a systematic review by Naugle et al.[13] isometric exercise has been found to be superior to aerobic and resistance exercises at reducing pain.

Rehabilitation[edit | edit source]

A variety of loading programs have been suggested for the treatment of patella tendinopathy with the main types being[14]:

  1. Eccentric loading
  2. Eccentric-concentric loading
Adapted from Malliaras et al. 2013
Program
Exercise type
Sets & reps
Frequency
Progression
Pain
Alfredson
Eccentric
3x15
Twice daily
Load
Enough load to achieve up to moderate pain
Stanish and Curwin/Silbernagel
Eccentric-concentric
3x10-20
Daily
Speed then load, type of exercise
Enough load to be painful in third set
Heavy slow resistance training
Eccentric-concentric
4x6-15
3x/week
6-15RM
Acceptable if was not worse after

Eccentric loading has been the most dominant approach for rehabilitation. Evidence suggests that all loading programs are beneficial in reducing pain and returning function however the eccentric-concentric type has greater patient subjective satisfaction[14]. This is perhaps due to time commitment and pain required from eccentric programs. Eccentric-concentric exercises can begin with body weight squats but a significant load is important. Gym machines such as leg press or knee extension provides control to the amount of loading. If suitable for the patient a barbell squat can be an excellent progression.

Protocol[edit | edit source]

Protocol as suggested by Malliaris et al. (2015)[1]
Stage
Indication to initiate
Dosage
1. Isometric loading
More than minimal pain during isometric exercise
5 repetitions of 45 seconds, 2 to 3 times per day; progress to 70% maximal voluntary contraction as pain allows
2. Isotonic loading
Minimal pain during isotonic exercise
3 to 4 sets at a load of 15RM, progressing to a load of 6RM, every second day; fatiguing load
3. Energy-storing loading
(A) Adequate strength and consistent with other side
(B) Load tolerance with initial-level energy storage exercise (ie, minimal pain during exercise and pain on load tests returning to baseline within 24 h)
Progressively develop volume and then intensity of relevant energy-storage exercise to replicate demands of sport
4. Return to sport
Load tolerance to energy-storage exercise progression that replicates demands of training
Progressively add training drills, then competition, when tolerant to full training

Differential Diagnosis[edit | edit source]

Key Evidence[edit | edit source]

  • Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy. (Rio 2015)
  • Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. (Malliaris 2015)
  • Physiotherapy management of patellar tendinopathy (jumper's knee). (Rudavsky 2014)
  • Achilles and patellar tendinopathy loading programmes. (Malliaris 2013)

Resources[edit | edit source]

Case Studies[edit | edit source]

Recent Related Research (from Pubmed)[edit | edit source]

Failed to load RSS feed from http://www.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=10AkQ1Iw49RKj2Dls_4vN-p0FB75-E6HcklAbWTJWvSBefDQfb|charset=UTF-8|short|max=10: Error parsing XML for RSS

References
[edit | edit source]

  1. 1.0 1.1 1.2 Malliaras P, Cook J, Purdam C, Rio E. Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. The Journal of orthopaedic and sports physical therapy. 2015 Sep:1-33.
  2. http://www.kumc.edu/instruction/medicine/anatomy/histoweb/
  3. Palastanga N, Field D, Soames R. Anatomy and human movement: structure and function. Elsevier Health Sciences; 2012.
  4. Lin TW, Cardenas L, Soslowsky LJ. Biomechanics of tendon injury and repair. Journal of biomechanics. 2004 Jun 30;37(6):865-77.
  5. Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV, Birk DE. Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development. Journal of cellular biochemistry. 2006 Aug 15;98(6):1436-49.
  6. McNeilly CM, Banes AJ, Benjamin M, Ralphs JR. Tendon cells in vivo form a three dimensional network of cell processes linked by gap junctions. Journal of anatomy. 1996 Dec;189(Pt 3):593
  7. Ferry ST, Dahners LE, Afshari HM, Weinhold PS. The effects of common anti-inflammatory drugs on the healing rat patellar tendon. The American journal of sports medicine. 2007 Aug 1;35(8):1326-33.
  8. Riley GP, Cox M, Harrall RL, Clements S, Hazleman BL. Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. Journal of Hand Surgery (British and European Volume). 2001 Jun 1;26(3):224-8.
  9. Fredberg U, Bolvig L, Pfeiffer‐Jensen M, Clemmensen D, Jakobsen BW, Stengaard‐Pedersen K. Ultrasonography as a tool for diagnosis, guidance of local steroid injection and, together with pressure algometry, monitoring of the treatment of athletes with chronic jumper's knee and Achilles tendinitis: a randomized, double‐blind, placebo‐controlled study. Scandinavian journal of rheumatology. 2004 Mar 1;33(2):94-101.
  10. Tallon C, Coleman BD, Khan KM, Maffulli N. Outcome of surgery for chronic Achilles tendinopathy a critical review. The American Journal of Sports Medicine. 2001 May 1;29(3):315-20.
  11. Maffulli N, Testa V, Capasso G, Oliva F, Sullo A, Benazzo F, Regine R, King JB. Surgery for chronic Achilles tendinopathy yields worse results in nonathletic patients. Clinical Journal of Sport Medicine. 2006 Mar 1;16(2):123-8.
  12. Simpson M, Smith T. Quadriceps tendinopathy-a forgotten pathology for physiotherapists? A systematic review of the current evidence-base. Phys Ther Rev. 2011;16(6):455-61.
  13. Naugle KM, Fillingim RB, Riley JL. A meta-analytic review of the hypoalgesic effects of exercise. The Journal of pain. 2012;13(12):1139-50.
  14. 14.0 14.1 Malliaras P, Barton CJ, Reeves ND, Langberg H. Achilles and patellar tendinopathy loading programmes. Sports Med. 2013;43(4):267-86.